| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0048 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |